Skip to main content
. 2013 May 1;2(5):e40. doi: 10.1038/psp.2013.16

Figure 5.

Figure 5

Personal challenges with DDM&S activities for (a) Academia (n = 73) and (b) Pharma (n = 38). Dark blue shade, major challenges; light blue shade, minor challenges; and white shade, none (multiple answers possible). DDM&S, drug disease modeling and simulation.